secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0000950170-24-053215
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical receives FDA 510(k) clearance for TabloCart with Prefiltration; resumes distribution
--------------------------------------------------------------------------------

- FDA granted 510(k) clearance for TabloCart with Prefiltration, an accessory for the Tablo Hemodialysis System.
- Outset has resumed distribution and has product available to ship to U.S. customers.
- TabloCart features three customizable prefiltration options and a booster pump for variable water conditions.
- CEO Leslie Trigg states clearance enhances flexibility for nurses and health systems from ICU to bedside.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024053215/0000950170-24-053215-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024053215/om-20240506.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-053215

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer